Status:
COMPLETED
Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Lead Sponsor:
University of Sao Paulo
Collaborating Sponsors:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
40+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of the study is to evaluate intravitreal injection of triamcinolone acetonide after laser panretinal photocoagulation in the treatment of proliferative diabetic retinopathy.
Detailed Description
The current gold standard for the treatment of proliferative diabetic retinopathy is panretinal photocoagulation. Therefore this study is designed using both treatments in the same patient: intravitre...
Eligibility Criteria
Inclusion
- Type II Diabetes
- symmetric proliferative diabetic retinopathy without high risk characteristics
- Informed consent signed
Exclusion
- previous treatment for diabetic retinopathy
- media opacities that may interfere with clinical, photographically or OCT examinations
- inability to understands the implications of the protocol
- Glaucoma or ocular hypertension
- Any other pathology that could cause retinal alterations
- Patients with any other situation that may interfere in study completion based in Investigator´s opinion
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
July 1 2006
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00443521
Start Date
March 1 2005
End Date
July 1 2006
Last Update
March 6 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Retina and Vitreous Service, Department of Ophthalmology. Hospital das Clínicas. University of São Paulo School of Medicine
São Paulo, São Paulo, Brazil, 05403-000